Founded in 1989, Vertex Pharmaceuticals Incorporated is a global biotechnology company headquartered in Boston, Massachusetts, with international headquarters in London. It is known for leading the development of transformative medicines for serious diseases. The company built its reputation through pioneering work in cystic fibrosis, where its medicines are treating more than 75,000 people in over 60 countries, and has since expanded into additional disease areas with approved therapies for sickle cell disease, transfusion-dependent beta thalassemia, and acute pain. Vertex operates in over 25 countries, employs 5,000 people across 21 countries, and in 2025 reported full-year revenue of USD 12.0 billion.
Updated 2026-03-19